JP2015505555A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015505555A5 JP2015505555A5 JP2014555310A JP2014555310A JP2015505555A5 JP 2015505555 A5 JP2015505555 A5 JP 2015505555A5 JP 2014555310 A JP2014555310 A JP 2014555310A JP 2014555310 A JP2014555310 A JP 2014555310A JP 2015505555 A5 JP2015505555 A5 JP 2015505555A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibition
- cancer
- compound
- protein kinase
- autoimmune disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1201566.5A GB201201566D0 (en) | 2012-01-30 | 2012-01-30 | New chemical compounds |
| GB1201566.5 | 2012-01-30 | ||
| PCT/GB2013/050212 WO2013114113A1 (en) | 2012-01-30 | 2013-01-30 | 1h-pyrrolo[2,3-b] pyridine derivatives and their use as kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015505555A JP2015505555A (ja) | 2015-02-23 |
| JP2015505555A5 true JP2015505555A5 (enExample) | 2015-11-12 |
| JP6199316B2 JP6199316B2 (ja) | 2017-09-20 |
Family
ID=45876325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014555310A Expired - Fee Related JP6199316B2 (ja) | 2012-01-30 | 2013-01-30 | １Ｈ−ピロロ［２，３−ｂ］ピリジン誘導体およびキナーゼ阻害剤としてのその使用 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US10000481B2 (enExample) |
| EP (1) | EP2809670B1 (enExample) |
| JP (1) | JP6199316B2 (enExample) |
| CN (4) | CN107011341A (enExample) |
| AU (1) | AU2013213954B2 (enExample) |
| BR (1) | BR112014018795B1 (enExample) |
| CA (1) | CA2862940C (enExample) |
| DK (1) | DK2809670T3 (enExample) |
| EA (1) | EA026657B1 (enExample) |
| ES (1) | ES2637340T3 (enExample) |
| GB (1) | GB201201566D0 (enExample) |
| HK (1) | HK1200447A1 (enExample) |
| HU (1) | HUE035332T2 (enExample) |
| IL (1) | IL233595B (enExample) |
| IN (1) | IN2014DN06104A (enExample) |
| MX (1) | MX352927B (enExample) |
| NZ (1) | NZ627361A (enExample) |
| PL (1) | PL2809670T3 (enExample) |
| PT (1) | PT2809670T (enExample) |
| WO (1) | WO2013114113A1 (enExample) |
| ZA (1) | ZA201405070B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201201566D0 (en) * | 2012-01-30 | 2012-03-14 | Vernalis R&D Ltd | New chemical compounds |
| AU2013252514B2 (en) * | 2012-04-23 | 2017-07-20 | Genentech, Inc. | Intermediates and processes for preparing compounds |
| KR102325163B1 (ko) * | 2013-08-22 | 2021-11-11 | 제넨테크, 인크. | 화합물의 제조 방법 |
| CN104829609B (zh) * | 2014-02-11 | 2016-08-03 | 北大方正集团有限公司 | 取代的吡啶并嘧啶化合物及其制备方法和应用 |
| MA41559A (fr) * | 2015-09-08 | 2017-12-26 | Taiho Pharmaceutical Co Ltd | Composé de pyrimidine condensé ou un sel de celui-ci |
| US10032914B2 (en) * | 2015-10-20 | 2018-07-24 | Taiwan Semiconductor Manufacturing Co., Ltd. | Semiconductor device and manufacturing method thereof |
| IL261107B2 (en) | 2016-02-23 | 2023-11-01 | Taiho Pharmaceutical Co Ltd | A novel compressed pyrimidine compound or a salt thereof |
| SG11202001212SA (en) | 2017-08-21 | 2020-03-30 | Taiho Pharmaceutical Co Ltd | Fusion protein of dctn1 protein with ret protein |
| WO2020150417A2 (en) | 2019-01-17 | 2020-07-23 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| CN111518096B (zh) | 2019-02-02 | 2022-02-11 | 江苏威凯尔医药科技有限公司 | 两面神激酶jak家族抑制剂及其制备和应用 |
| CN114728949B (zh) | 2019-08-01 | 2024-11-12 | 曙方医药 | 作为激酶抑制剂的杂环化合物及其用途 |
| IT202000005527A1 (it) * | 2020-03-16 | 2021-09-16 | Univ Degli Studi Di Trento | Trattamento terapeutico di cromatinopatie |
| EP4182310A1 (en) | 2020-07-15 | 2023-05-24 | IFM Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| US20230365553A1 (en) * | 2020-07-15 | 2023-11-16 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| TW202216685A (zh) * | 2020-07-15 | 2022-05-01 | 美商Ｉｆｍ Ｄｕｅ有限公司 | 用於治療與sting活性相關的病狀之化合物及組合物 |
| WO2022150585A1 (en) | 2021-01-08 | 2022-07-14 | Ifm Due, Inc. | Heterobicyclic compounds having an urea or analogue and their compositions for treating conditions associated with sting activity |
| PY2269135A (es) | 2021-08-10 | 2024-01-29 | Ifm Due Inc | Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting |
| WO2023137034A1 (en) * | 2022-01-12 | 2023-07-20 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| CN116554170A (zh) * | 2023-04-26 | 2023-08-08 | 上海大学 | 4-氟-7-氮杂吲哚的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1012976A (en) * | 1909-03-25 | 1911-12-26 | Adolf Bordt | Adding-machine. |
| WO2003028724A1 (en) * | 2001-10-04 | 2003-04-10 | Smithkline Beecham Corporation | Chk1 kinase inhibitors |
| US7531553B2 (en) * | 2003-03-21 | 2009-05-12 | Amgen Inc. | Heterocyclic compounds and methods of use |
| US20050130954A1 (en) * | 2003-11-21 | 2005-06-16 | Mitchell Ian S. | AKT protein kinase inhibitors |
| CN101959887B (zh) * | 2008-01-08 | 2013-07-31 | 阵列生物制药公司 | 作为激酶抑制剂的吡咯并吡啶 |
| JP5386508B2 (ja) | 2008-01-22 | 2014-01-15 | ヴァーナリス アールアンドディー リミテッド | インドリル−ピリドン誘導体類 |
| AR071717A1 (es) * | 2008-05-13 | 2010-07-07 | Array Biopharma Inc | Pirrolo[2,3-b]piridinas inhibidoras de quinasas chk1 y chk2,composiciones farmaceuticas que las contienen,proceso para prepararlas y uso de las mismas en el tratamiento y prevencion del cancer. |
| US20110124654A1 (en) | 2008-06-11 | 2011-05-26 | Huifen Chen | Diazacarbazoles and methods of use |
| MX2012001419A (es) * | 2009-08-06 | 2012-03-16 | Merck Patent Gmbh | Compuestos biciclicos novedosos de urea. |
| WO2011146313A1 (en) * | 2010-05-19 | 2011-11-24 | The University Of North Carolina At Chapel Hill | Pyrazolopyrimidine compounds for the treatment of cancer |
| GB201201566D0 (en) | 2012-01-30 | 2012-03-14 | Vernalis R&D Ltd | New chemical compounds |
-
2012
- 2012-01-30 GB GBGB1201566.5A patent/GB201201566D0/en not_active Ceased
-
2013
- 2013-01-30 DK DK13703121.7T patent/DK2809670T3/en active
- 2013-01-30 CN CN201610920724.7A patent/CN107011341A/zh active Pending
- 2013-01-30 EA EA201491376A patent/EA026657B1/ru not_active IP Right Cessation
- 2013-01-30 NZ NZ627361A patent/NZ627361A/en not_active IP Right Cessation
- 2013-01-30 HK HK15100794.1A patent/HK1200447A1/xx unknown
- 2013-01-30 CN CN201610920720.9A patent/CN106866658B/zh not_active Expired - Fee Related
- 2013-01-30 BR BR112014018795-9A patent/BR112014018795B1/pt not_active IP Right Cessation
- 2013-01-30 ES ES13703121.7T patent/ES2637340T3/es active Active
- 2013-01-30 WO PCT/GB2013/050212 patent/WO2013114113A1/en not_active Ceased
- 2013-01-30 US US14/375,353 patent/US10000481B2/en active Active
- 2013-01-30 PT PT137031217T patent/PT2809670T/pt unknown
- 2013-01-30 CN CN201380014717.5A patent/CN104203948A/zh active Pending
- 2013-01-30 EP EP13703121.7A patent/EP2809670B1/en active Active
- 2013-01-30 CA CA2862940A patent/CA2862940C/en active Active
- 2013-01-30 IN IN6104DEN2014 patent/IN2014DN06104A/en unknown
- 2013-01-30 CN CN202010405942.3A patent/CN111484493A/zh active Pending
- 2013-01-30 HU HUE13703121A patent/HUE035332T2/en unknown
- 2013-01-30 MX MX2014009112A patent/MX352927B/es active IP Right Grant
- 2013-01-30 PL PL13703121T patent/PL2809670T3/pl unknown
- 2013-01-30 JP JP2014555310A patent/JP6199316B2/ja not_active Expired - Fee Related
- 2013-01-30 AU AU2013213954A patent/AU2013213954B2/en active Active
-
2014
- 2014-07-10 IL IL233595A patent/IL233595B/en active IP Right Grant
- 2014-07-11 ZA ZA2014/05070A patent/ZA201405070B/en unknown
-
2018
- 2018-06-15 US US16/009,439 patent/US10889582B2/en active Active
-
2020
- 2020-11-30 US US17/107,176 patent/US20210206762A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL259253B (en) | Drowsiness onset detection | |
| IL244748B (en) | Methods and processes for non-invasive assessment of genetic variations | |
| JP2017537928A5 (enExample) | ||
| JP2015125255A5 (enExample) | ||
| EP2951139A4 (en) | SYNTHESIS FROM 1,1,2,3-TETRACHLORPROPENE | |
| JP2015503422A5 (enExample) | ||
| IL242056B (en) | Registration maps using intra-cardiac signals | |
| HUE040434T2 (hu) | Szelektív CDK4/6 inhibitor szilárd alakjai | |
| EP3730050C0 (en) | DETERMINATION OF REFERENCE ANNOTATION TIME FROM MULTI-CHANNEL ELECTROCARDIOGRAM SIGNALS | |
| HUE056006T2 (hu) | Kombináció Parkinson-kór kezelésére | |
| EP2971207A4 (en) | PREPARATION OF ALUMINUM SCANDIUM ALLOYS | |
| HUE043206T2 (hu) | Kortisztatin-analógok gyulladásos és/vagy immunbetegségek kezelésére | |
| EP3008124A4 (en) | STRENGTH COMPOSITIONS AND USE THEREOF | |
| PL3487491T3 (pl) | Kompozycje do zwiększenia aktywności mózgu | |
| EP3506254A4 (en) | SOUNDPROOF STRUCTURE | |
| PL3414361T3 (pl) | Grafen i wytwarzanie grafenu | |
| IL252886A0 (en) | Processes and systems for catalytic manufacture of wax ester derivatives | |
| PL3226888T3 (pl) | Podawanie selektywnego transsygnałowego inhibitora IL-6 | |
| IL263221B (en) | Epicardial mapping | |
| WO2015066485A3 (en) | Mitochondrial disease genetic diagnostics | |
| ES1117305Y (es) | Despertador para activar la incorporación del usuario. | |
| MacKay | The engine of memory | |
| JP2017516883A5 (enExample) | ||
| IL243550A0 (en) | Therapeutic agent for disease based on inhibitory effect of macrophage migration inhibitory factor | |
| Gravotta | THE UNADVERTISED USES OF DRUGS |